Prosecution Insights
Last updated: November 20, 2026

Susan Emily Fernandez, USPTO Patent Examiner

Listed by the USPTO as FERNANDEZ, SUSAN EMILY

Tech Center 1600 • Art Units: 1651 1653 1656 1682

This examiner grants 52% of resolved cases

Analysis

Fernandez, Susan Emily, handles cases in Tech Center 1600 and Art Unit 1651. The record includes 566 resolved cases, with an allowance rate of 52.5% and a median of 1360 days to allowance. The interview lift is 60.7%, making interviews a major strategic consideration in a profile that also reflects a long prosecution path.

The listed companies are Cedars-Sinai Medical Center, The Regents of the University of California, and Nutricia. The leading firms are Nixon Peabody LLP, Leason Ellis LLP, and BANNER & WITCOFF, LTD. Practitioners should consider focused interview preparation, careful amendment planning, and realistic expectations for time to allowance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

52.5%
Allow Rate
-7.5% vs TC avg
615
Total Applications
+60.7%
Interview Lift
1360
Avg Prosecution Days
Based on 566 resolved cases, 2023–2026

Rejection Statute Breakdown

6.5%
§101 Eligibility
10.4%
§102 Novelty
40.7%
§103 Obviousness
32.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18728813 Listeria Variants and Methods of Use Thereof Non-Final OA The Regents of the University of California
17572011 PRODUCING METHOD FOR ORGANISM-DERIVED MATERIAL, PRODUCING METHOD FOR PRODUCT, AND VOLTAGE APPLYING DEVICE Final Rejection FUJIFILM Corporation
18012059 Concrete with Improved Environmental Impact Final Rejection Locus Solutions IPCo, LLC
18845311 METHODS AND COMPOSITIONS FOR SUPPRESSION OF BIOGENIC AMINES PRODUCED BY THE GUT MICROBIOME Non-Final OA Cedars-Sinai Medical Center
17565834 METHODS OF DIAGNOSIS, SELECTION, AND TREATMENT OF DISEASES AND CONDITIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS Final Rejection Cedars-Sinai Medical Center
19105296 BIFIDOBACTERIUM BREVE, COMPOSITION COMPRISING BIFIDOBACTERIUM BREVE OR CULTURE THEREOF, AND USE OF BIFIDOBACTERIUM BREVE OR CULTURE THEREOF Non-Final OA TCI CO., LTD.
18865063 NOVEL LACTIC ACID BACTERIUM, AND COMPOSITION, FOOD OR BEVERAGE, AND PHARMACEUTICAL PRODUCT CONTAINING LACTIC ACID BACTERIUM Non-Final OA MITSUBISHI GAS CHEMICAL COMPANY, INC.
18988370 FREEZE-DRIED PROBIOTIC FOODSTUFFS Non-Final OA IMAGILIN TECHNOLOGY, LLC
18835611 LACTIC ACID BACTERIUM-CONTAINING TABLETS Final Rejection KIRIN HOLDINGS KABUSHIKI KAISHA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Susan Emily Fernandez's allowance rate?

52.5% of resolved applications examined by Susan Emily Fernandez were allowed (566 resolved cases), compared with 31.5% across Art Unit 1651 over the last five years.

Does an interview help with examiner Susan Emily Fernandez?

This examiner's interview lift is +60.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Susan Emily Fernandez take to allow a patent?

Applications allowed by Susan Emily Fernandez took 1,360 days on average from filing to allowance.

Which art unit does examiner Susan Emily Fernandez work in?

Susan Emily Fernandez examines applications in Art Unit 1651 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month